Alan Sinclair (scientist)
Alan James Sinclair is a British physician and academic specializing in diabetes in older people, geriatric medicine and frailty. He is a Professor in Diabetes Care at King’s College London and Director of the Foundation for Diabetes Research in Older People. He is known for his work in the development of clinical guidelines, research translation and service delivery for older-people’s diabetes.
Early life
He was born in Newcastle-under-Lyme and was a pupil at Newcastle High School where he played rugby and cricket for the school, which he left in 1972.Education
He earned a first-class honours BSc in Biochemistry from the University of London in 1976, followed by an MB BS from St Bartholomew’s Hospital Medical College, University of London, in 1979. He obtained his MD from the University of London in 1992 and an MSc in Medicine from the University of Sydney in 1993. He holds specialist recognition from the General Medical Council in geriatric medicine, general internal medicine, and diabetes/endocrinology.Career
Sinclair has held senior academic and clinical appointments in several UK universities and NHS trusts. He was Professor of Medicine and Dean at the Bedfordshire & Hertfordshire Postgraduate Medical School and the University of Bedfordshire, and served as Honorary Consultant Geriatrician and Diabetologist. He later became Visiting Chair in Metabolic Medicine at Aston University and Visiting Professor in Diabetes Care at King’s College London. He founded the Institute of Diabetes for Older People in 2008 and has served as Director of fDROP, a UK organisation dedicated to research, education and policy in diabetes and older people. In the NHS clinical arena, he has held roles such as Director of Diabetes Frail Ltd and Honorary Consultant Physician in Diabetes at Birmingham Heartlands Hospital.Sinclair has a long record of leadership in service development, professional education, national strategy, and international guideline development. He served as the first National Clinical Lead for Diabetes in Older People appointed by the Department of Health (UK)/NHS-Diabetes in England.
He chaired the European Diabetes Working Party for Older People for nearly 15 years, producing four sets of international clinical guidelines on diabetes in older people. He has advised numerous institutions including the National Institute for Health and Care Excellence, Diabetes UK, the British Geriatrics Society, the Care Quality Commission, and international bodies such as the World Health Organization and the International Association of Gerontology & Geriatrics.
Research
Sinclair has examined the use of technology in diabetes management for older adults, including continuous glucose monitoring, insulin pumps, and automated insulin delivery systems, noting that age-related limitations may require tailored education and support. His work has influenced international guidelines and policy, including advocacy for frailty as a care indicator in older adults with diabetes.He has chaired and contributed to networks such as the European Diabetes Working Party for Older People and the Foundation for Diabetes Research in Older People / Diabetes Frail platform, focusing on clinical and translational research.
Sinclair has also investigated personalized therapeutic strategies, including the appropriate use of SGLT-2 inhibitors or GLP-1 receptor agonists and the de-intensification of hypoglycemic therapy in malnourished or frail individuals. His research further explores the interactions between multimorbidity, frailty, and diabetes in older adults, highlighting their impact on outcomes and care needs.